Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 open-label rhPTH (1-84) study in Japanese adults with chronic hypoparathyroidism
jRCT2080224751Phase 3Not yet recruiting
- Sponsor
- Takeda
- Start
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of parathyroid hormone 1-84 in chronic hypoparathyroidism, sponsored by Takeda. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
parathyroid hormone 1-84
03
Conditions
chronic hypoparathyroidism
Beyond the preview
Go deeper on jRCT2080224751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224751.